ROIV
insider transactionsRoivant Sciences Ltd. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 365d
-31.9M
3.3K buy · 31.9M sell
Net value · 365d
-$698.6M
$50.0K in · $698.6M out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
91
3.3K buy · 31.9M sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Exercise·M
Venker Eric KEY
President & Immunovant CEO · 10b5-1
$0
200.0K sh
Own +5%
-
Sell·S
Venker Eric KEY
President & Immunovant CEO · 10b5-1
$6.1M
200.0K sh · $30.27
Own -11%
-
Exercise·M
Venker Eric KEY
President & Immunovant CEO · 10b5-1
$770.0K
200.0K sh · $3.85
Own +12%
-
Other·F
Venker Eric KEY
President & Immunovant CEO · 10b5-1
$1.1M
34.5K sh · $32.41
Own -2%
-
Other·F
Pulik Richard KEY
CFO
$614.6K
19.0K sh · $32.41
Own -6%
-
Exercise·M
Venker Eric KEY
President & Immunovant CEO · 10b5-1
$0
200.0K sh
Own +4%
-
Sell·S
Venker Eric KEY
President & Immunovant CEO · 10b5-1
$5.9M
200.0K sh · $29.59
Own -11%
-
Exercise·M
Venker Eric KEY
President & Immunovant CEO · 10b5-1
$770.0K
200.0K sh · $3.85
Own +12%
-
Grant·A
Pulik Richard KEY
CFO
$0
84.0K sh
Own New
-
Grant·A
Pulik Richard KEY
CFO
$0
60.6K sh
Own +26%
-
Grant·A
Chief Accounting Officer
$0
27.2K sh
Own New
-
Grant·A
Chief Accounting Officer
$0
29.2K sh
Own +35%
-
Other·F
Director
$2.8K
95 sh · $29.83
Own -0%
-
Grant·A
Director
$0
896 sh
Own +1%
-
Other·F
Director
$2.8K
94 sh · $29.83
Own -0%
-
Grant·A
Director
$0
469 sh
Own +0%
-
Grant·A
Director
$0
670 sh
Own +4%
-
Sell·S
Gline Matthew KEY
CEO
$8.4M
289.8K sh · $29.16
Own -2%
-
Sell·S
Chief Accounting Officer
$384.1K
13.5K sh · $28.37
Own -14%
-
Other·F
Sukhatme Mayukh KEY
President & CIO
$5.2M
187.5K sh · $27.70
Own -1%
-
Other·F
Gline Matthew KEY
CEO
$8.4M
304.7K sh · $27.70
Own -2%
-
Other·F
Torti Frank KEY
President and Vant Chair
$4.4M
160.0K sh · $27.70
Own -1%
-
Exercise·M
Sukhatme Mayukh KEY
President & CIO
$15.0M
1.3M sh · $11.50
Own New
-
Other·F
Sukhatme Mayukh KEY
President & CIO
$787.3K
29.8K sh · $26.41
Own -0%
-
Exercise·M
Sukhatme Mayukh KEY
President & CIO
—
58.4K sh
Own +0%
-
Exercise·M
Gline Matthew KEY
CEO
$25.0M
2.2M sh · $11.50
Own New
-
Other·F
Gline Matthew KEY
CEO
$1.4M
53.8K sh · $26.41
Own -0%
-
Exercise·M
Gline Matthew KEY
CEO
—
97.3K sh
Own +1%
-
Exercise·M
Director
$0
70.0K sh
Own New
-
Sell·S
Director
$1.9M
70.0K sh · $27.45
Own -62%
-
Exercise·M
Director
$616.0K
70.0K sh · $8.80
Own +163%
-
Other·F
Chief Accounting Officer
$402.4K
14.5K sh · $27.70
Own -13%
-
Other·F
Pulik Richard KEY
CFO
$42.8K
1.5K sh · $27.70
Own -1%
-
Exercise·M
Venker Eric KEY
President & Immunovant CEO · 10b5-1
$0
200.0K sh
Own +4%
-
Exercise·M
Venker Eric KEY
President & Immunovant CEO · 10b5-1
$770.0K
200.0K sh · $3.85
Own +12%
-
Sell·S
Venker Eric KEY
President & Immunovant CEO · 10b5-1
$5.6M
200.0K sh · $28.24
Own -11%
-
Sell·S
Director
$1.2M
41.9K sh · $28.68
Own -73%
-
Exercise·M
Torti Frank KEY
President and Vant Chair · 10b5-1
$0
587.4K sh
Own +24%
-
Sell·S
Torti Frank KEY
President and Vant Chair · 10b5-1
$16.2M
587.4K sh · $27.51
Own -4%
-
Exercise·M
Torti Frank KEY
President and Vant Chair · 10b5-1
$2.3M
587.4K sh · $3.85
Own +4%
-
Exercise·M
Torti Frank KEY
President and Vant Chair · 10b5-1
$0
1.0M sh
Own +39%
-
Sell·S
Torti Frank KEY
President and Vant Chair · 10b5-1
$27.5M
1.0M sh · $27.15
Own -7%
-
Exercise·M
Torti Frank KEY
President and Vant Chair · 10b5-1
$3.9M
1.0M sh · $3.85
Own +7%
-
Other·F
Pulik Richard KEY
CFO
$27.1K
1.0K sh · $27.15
Own -0%
-
Other·F
Venker Eric KEY
President & Immunovant CEO
$191.4K
7.1K sh · $27.15
Own -0%
-
Exercise·M
Torti Frank KEY
President and Vant Chair · 10b5-1
$0
1.4M sh
Own +43%
-
Sell·S
Torti Frank KEY
President and Vant Chair · 10b5-1
$38.4M
1.4M sh · $27.42
Own -9%
-
Exercise·M
Torti Frank KEY
President and Vant Chair · 10b5-1
$5.4M
1.4M sh · $3.85
Own +10%
-
Sell·S
Other
$4.0M
150.8K sh · $26.49
Own -1%
-
Sell·S
Other
$6.0M
225.0K sh · $26.50
Own -1%
-
Sell·S
Director
$6.0M
225.0K sh · $26.50
Own -1%
-
Sell·S
Director
$4.0M
150.8K sh · $26.49
Own -1%
-
Sell·S
Director
$4.0M
150.8K sh · $26.49
Own -1%
-
Sell·S
Director
$6.0M
225.0K sh · $26.50
Own -1%
-
Exercise·M
Venker Eric KEY
President & Immunovant CEO · 10b5-1
$0
200.0K sh
Own +4%
-
Exercise·M
Venker Eric KEY
President & Immunovant CEO · 10b5-1
$770.0K
200.0K sh · $3.85
Own +12%
-
Sell·S
Venker Eric KEY
President & Immunovant CEO · 10b5-1
$5.3M
200.0K sh · $26.49
Own -11%
-
Sell·S
Other
$7.4M
275.0K sh · $26.76
Own -2%
-
Sell·S
Other
$4.0M
150.0K sh · $26.72
Own -1%
-
Sell·S
Director
$4.0M
150.0K sh · $26.72
Own -1%
-
Sell·S
Director
$7.4M
275.0K sh · $26.76
Own -2%
-
Sell·S
Director
$7.4M
275.0K sh · $26.76
Own -2%
-
Sell·S
Director
$4.0M
150.0K sh · $26.72
Own -1%
-
Sell·S
Other
$11.3M
425.0K sh · $26.67
Own -3%
-
Sell·S
Director
$11.3M
425.0K sh · $26.67
Own -3%
-
Sell·S
Director
$11.3M
425.0K sh · $26.67
Own -3%
-
Exercise·M
Sukhatme Mayukh KEY
President & CIO
$0
651.6K sh
Own New
-
Other·J
Sukhatme Mayukh KEY
President & CIO
$8.3M
312.1K sh · $26.47
-
Exercise·M
Sukhatme Mayukh KEY
President & CIO
$8.3M
651.6K sh · $12.68
Own +3%
-
Sell·S
Sukhatme Mayukh KEY
President & CIO
$9.0M
339.4K sh · $26.47
Own -2%
-
Other·F
Director
$2.8K
124 sh · $22.98
Own -0%
-
Grant·A
Director
$0
1.2K sh
Own +1%
-
Grant·A
Director
$0
815 sh
Own +1%
-
Other·F
Director
$1.2K
54 sh · $22.98
Own -0%
-
Grant·A
Director
$0
609 sh
Own +1%
-
Other·F
Director
$2.8K
122 sh · $22.98
Own -0%
-
Exercise·M
Venker Eric KEY
President & Immunovant CEO · 10b5-1
$0
200.0K sh
Own +4%
-
Exercise·M
Venker Eric KEY
President & Immunovant CEO · 10b5-1
$770.0K
200.0K sh · $3.85
Own +12%
-
Sell·S
Venker Eric KEY
President & Immunovant CEO · 10b5-1
$4.4M
200.0K sh · $21.92
Own -11%
-
Exercise·M
Sukhatme Mayukh KEY
President & CIO
$0
2.4M sh
Own New
-
Exercise·M
Sukhatme Mayukh KEY
President & CIO
$31.1M
2.4M sh · $12.68
Own +13%
-
Sell·S
Sukhatme Mayukh KEY
President & CIO
$22.1M
1.0M sh · $21.71
Own -5%
-
Other·J
Sukhatme Mayukh KEY
President & CIO
$31.1M
1.4M sh · $21.71
-
Exercise·M
Sukhatme Mayukh KEY
President & CIO
$0
748.4K sh
Own New
-
Other·J
Sukhatme Mayukh KEY
President & CIO
$9.5M
436.5K sh · $21.74
-
Exercise·M
Sukhatme Mayukh KEY
President & CIO
$9.5M
748.4K sh · $12.68
Own +4%
-
Sell·S
Sukhatme Mayukh KEY
President & CIO
$6.8M
311.9K sh · $21.74
Own -2%
-
Other·G
Torti Frank KEY
President and Vant Chair
$0
110.5K sh
Own -1%
-
Other·J
Torti Frank KEY
President and Vant Chair
$1.5M
64.9K sh · $22.47
-
Exercise·M
Venker Eric KEY
President & Immunovant CEO
$0
117.8K sh
Own +2%
-
Exercise·M
Venker Eric KEY
President & Immunovant CEO
$453.7K
117.8K sh · $3.85
Own +7%
-
Sell·S
Venker Eric KEY
President & Immunovant CEO
$1.7M
75.0K sh · $22.53
Own -4%
-
Grant·A
Torti Frank KEY
President and Vant Chair
$3.9M
175.4K sh · $22.45
Own +1%
-
Exercise·M
Pulik Richard KEY
CFO
$0
260.0K sh
Own +54%
-
Exercise·M
Pulik Richard KEY
CFO
$1.0M
260.0K sh · $3.85
Own +67%
-
Sell·S
Pulik Richard KEY
CFO
$5.8M
260.0K sh · $22.45
Own -40%
-
Sell·S
Pulik Richard KEY
CFO
$3.3M
146.7K sh · $22.39
Own -38%
-
Exercise·M
Venker Eric KEY
President & Immunovant CEO
$0
313.8K sh
Own +6%
-
Exercise·M
Venker Eric KEY
President & Immunovant CEO
$1.2M
313.8K sh · $3.85
Own +21%
-
Sell·S
Venker Eric KEY
President & Immunovant CEO
$4.5M
200.0K sh · $22.45
Own -11%
-
Other·F
Pulik Richard KEY
CFO
$47.7K
2.1K sh · $22.41
Own -1%
-
Sell·S
Director
$3.6M
155.1K sh · $23.02
Own -1%
-
Sell·S
Director
$10.0M
432.7K sh · $23.05
Own -3%
-
Sell·S
Director
$4.4M
189.5K sh · $23.17
Own -1%
-
Sell·S
Director
$10.0M
432.7K sh · $23.05
Own -3%
-
Sell·S
Director
$3.6M
155.1K sh · $23.02
Own -1%
-
Sell·S
Director
$4.4M
189.5K sh · $23.17
Own -1%
-
Sell·S
Other
$3.6M
155.1K sh · $23.02
Own -1%
-
Sell·S
Other
$4.4M
189.5K sh · $23.17
Own -1%
-
Sell·S
Other
$10.0M
432.7K sh · $23.05
Own -3%
-
Exercise·M
Sukhatme Mayukh KEY
President & CIO
$0
59.5K sh
Own +5%
-
Exercise·M
Sukhatme Mayukh KEY
President & CIO
$754.6K
59.5K sh · $12.68
Own +0%
-
Sell·S
Sukhatme Mayukh KEY
President & CIO
$619.5K
26.8K sh · $23.09
Own -0%
-
Other·J
Sukhatme Mayukh KEY
President & CIO
$754.6K
32.7K sh · $23.09
-
Sell·S
Director
$14.8M
642.3K sh · $23.08
Own -4%
-
Sell·S
Director
$6.3M
275.0K sh · $22.93
Own -2%
-
Sell·S
Director
$6.3M
275.0K sh · $22.93
Own -2%
-
Sell·S
Director
$14.8M
642.3K sh · $23.08
Own -4%
-
Sell·S
Other
$6.3M
275.0K sh · $22.93
Own -2%
-
Sell·S
Other
$14.8M
642.3K sh · $23.08
Own -4%
-
Exercise·M
TenPercentOwner
$0
832.5K sh
Own +4%
-
Sell·S
TenPercentOwner
$7.8M
353.7K sh · $22.05
Own -1%
-
Exercise·M
TenPercentOwner
$10.6M
832.5K sh · $12.68
Own +2%
-
Other·J
TenPercentOwner
$10.6M
478.7K sh · $22.05
-
Exercise·M
Gline Matthew KEY
CEO
$0
1.4M sh
Own New
-
Exercise·M
Gline Matthew KEY
CEO
$0
234.1K sh
Own New
-
Exercise·M
Gline Matthew KEY
CEO
$0
2.3M sh
Own New
-
Other·J
Gline Matthew KEY
CEO
$28.8M
1.3M sh · $21.68
-
Other·J
Gline Matthew KEY
CEO
$17.3M
797.6K sh · $21.68
-
Sell·S
Gline Matthew KEY
CEO
$12.3M
566.1K sh · $21.68
Own -3%
-
Exercise·M
Gline Matthew KEY
CEO
$17.3M
1.4M sh · $12.68
Own +8%
-
Sell·S
Gline Matthew KEY
CEO
$5.0M
230.4K sh · $21.68
Own -1%
-
Exercise·M
Gline Matthew KEY
CEO
$950.4K
234.1K sh · $4.06
Own +1%
-
Exercise·M
Gline Matthew KEY
CEO
$28.8M
2.3M sh · $12.68
Own +13%
-
Other·J
Gline Matthew KEY
CEO
$81.1K
3.7K sh · $21.68
-
Sell·S
Gline Matthew KEY
CEO
$20.5M
943.5K sh · $21.68
Own -5%
-
Exercise·M
TenPercentOwner
$0
4.7M sh
Own +26%
-
Sell·S
TenPercentOwner
$43.4M
2.0M sh · $21.96
Own -5%
-
Other·J
TenPercentOwner
$59.2M
2.7M sh · $21.96
-
Exercise·M
TenPercentOwner
$59.3M
4.7M sh · $12.68
Own +14%
-
Exercise·M
TenPercentOwner
$0
1.9M sh
Own +7%
-
Other·J
TenPercentOwner
$23.7M
1.1M sh · $21.64
-
Sell·S
TenPercentOwner
$16.8M
774.1K sh · $21.64
Own -2%
-
Exercise·M
TenPercentOwner
$23.7M
1.9M sh · $12.68
Own +6%
-
Exercise·M
Venker Eric KEY
President & Immunovant CEO · 10b5-1
$0
200.0K sh
Own +4%
-
Sell·S
Venker Eric KEY
President & Immunovant CEO · 10b5-1
$4.2M
200.0K sh · $20.85
Own -12%
-
Exercise·M
Venker Eric KEY
President & Immunovant CEO · 10b5-1
$770.0K
200.0K sh · $3.85
Own +13%
-
Other·F
Venker Eric KEY
President & Immunovant CEO
$142.9K
7.1K sh · $20.27
Own -0%
-
Other·F
Pulik Richard KEY
CFO
$25.0K
1.2K sh · $20.27
Own -0%
-
Sell·S
Other
$3.0M
150.0K sh · $20.20
Own -1%
-
Sell·S
Other
$2.5M
125.0K sh · $20.16
Own -1%
-
Sell·S
Other
$3.5M
175.0K sh · $20.24
Own -1%
-
Sell·S
Other
$17.2M
850.0K sh · $20.25
Own -4%
-
Sell·S
Director
$3.5M
175.0K sh · $20.24
Own -1%
-
Sell·S
Director
$2.5M
125.0K sh · $20.16
Own -1%
-
Sell·S
Director
$3.0M
150.0K sh · $20.20
Own -1%
-
Sell·S
Director
$17.2M
850.0K sh · $20.25
Own -4%
-
Sell·S
Director
$17.2M
850.0K sh · $20.25
Own -4%
-
Sell·S
Director
$3.5M
175.0K sh · $20.24
Own -1%
-
Sell·S
Director
$2.5M
125.0K sh · $20.16
Own -1%
-
Sell·S
Director
$3.0M
150.0K sh · $20.20
Own -1%
-
Sell·S
TenPercentOwner
$11.1M
539.6K sh · $20.51
Own -2%
-
Sell·S
TenPercentOwner
$20.9M
1.0M sh · $20.33
Own -3%
-
Sell·S
TenPercentOwner
$6.0M
287.3K sh · $20.81
Own -1%
-
Exercise·M
Venker Eric KEY
President & Immunovant CEO · 10b5-1
$4.0M
200.0K sh · $20.22
Own +3%
-
Sell·S
Venker Eric KEY
President & Immunovant CEO · 10b5-1
$4.0M
200.0K sh · $20.22
Own -12%
-
Exercise·M
Venker Eric KEY
President & Immunovant CEO · 10b5-1
$770.0K
200.0K sh · $3.85
Own +13%
-
Other·F
Director
$2.8K
158 sh · $17.74
Own -0%
-
Grant·A
Director
$0
789 sh
Own +1%
-
Grant·A
Director
$0
1.1K sh
Own +2%
-
Other·F
Director
$5.0K
281 sh · $17.74
Own -0%
-
Grant·A
Director
$0
1.5K sh
Own +1%
-
Exercise·M
Venker Eric KEY
President & Immunovant CEO · 10b5-1
$0
118.4K sh
Own New
-
Exercise·M
Venker Eric KEY
President & Immunovant CEO · 10b5-1
$1.9M
118.4K sh · $15.85
Own +8%
-
Sell·S
Venker Eric KEY
President & Immunovant CEO · 10b5-1
$2.0M
118.4K sh · $17.06
Own -7%
-
Exercise·M
Venker Eric KEY
President & Immunovant CEO · 10b5-1
$0
318.3K sh
Own New
-
Exercise·M
Venker Eric KEY
President & Immunovant CEO · 10b5-1
$5.0M
318.3K sh · $15.85
Own +21%
-
Sell·S
Venker Eric KEY
President & Immunovant CEO · 10b5-1
$5.4M
318.3K sh · $17.05
Own -17%
-
Exercise·M
Venker Eric KEY
President & Immunovant CEO · 10b5-1
$0
414.7K sh
Own +1883%
-
Sell·S
Venker Eric KEY
President & Immunovant CEO · 10b5-1
$7.0M
414.7K sh · $16.93
Own -22%
-
Exercise·M
Venker Eric KEY
President & Immunovant CEO · 10b5-1
$6.6M
414.7K sh · $15.85
Own +28%
-
Exercise·M
Venker Eric KEY
President & Immunovant CEO · 10b5-1
$0
20.7K sh
Own +2%
-
Exercise·M
Venker Eric KEY
President & Immunovant CEO · 10b5-1
$328.5K
20.7K sh · $15.85
Own +1%
-
Sell·S
Venker Eric KEY
President & Immunovant CEO · 10b5-1
$336.8K
20.7K sh · $16.25
Own -1%
-
Exercise·M
Venker Eric KEY
President & Immunovant CEO · 10b5-1
$0
104.9K sh
Own +14%
-
Sell·S
Venker Eric KEY
President & Immunovant CEO · 10b5-1
$1.7M
104.9K sh · $16.30
Own -7%
-
Exercise·M
Venker Eric KEY
President & Immunovant CEO · 10b5-1
$1.7M
104.9K sh · $15.85
Own +7%
-
Exercise·M
Venker Eric KEY
President & Immunovant CEO · 10b5-1
$0
10.3K sh
Own +1%
-
Exercise·M
Venker Eric KEY
President & Immunovant CEO · 10b5-1
$0
128.3K sh
Own New
-
Sell·S
Venker Eric KEY
President & Immunovant CEO · 10b5-1
$2.2M
138.6K sh · $16.20
Own -8%
-
Exercise·M
Venker Eric KEY
President & Immunovant CEO · 10b5-1
$955.8K
128.3K sh · $7.45
Own +8%
-
Exercise·M
Venker Eric KEY
President & Immunovant CEO · 10b5-1
$163.4K
10.3K sh · $15.85
Own +1%
-
Exercise·M
Venker Eric KEY
President & Immunovant CEO · 10b5-1
$0
67.2K sh
Own +7%
-
Exercise·M
Venker Eric KEY
President & Immunovant CEO · 10b5-1
$0
107.1K sh
Own +506%
-
Exercise·M
Venker Eric KEY
President & Immunovant CEO · 10b5-1
$0
180.9K sh
Own +3%
-
Exercise·M
Venker Eric KEY
President & Immunovant CEO · 10b5-1
$798.1K
107.1K sh · $7.45
Own +7%
-
Sell·S
Venker Eric KEY
President & Immunovant CEO · 10b5-1
$5.7M
355.2K sh · $16.15
Own -19%
-
Exercise·M
Venker Eric KEY
President & Immunovant CEO · 10b5-1
$696.3K
180.9K sh · $3.85
Own +11%
-
Exercise·M
Venker Eric KEY
President & Immunovant CEO · 10b5-1
$1.1M
67.2K sh · $15.85
Own +4%
-
Exercise·M
Venker Eric KEY
President & Immunovant CEO · 10b5-1
$0
127.4K sh
Own +14%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| May 22, 2026 | Venker Eric KEY 10b5-1 | Exercise M | 200.0K | $0 |
| May 22, 2026 | Venker Eric KEY 10b5-1 | Sell S | 200.0K | $6.1M |
| May 22, 2026 | Venker Eric KEY 10b5-1 | Exercise M | 200.0K | $770.0K |
| May 20, 2026 | Venker Eric KEY 10b5-1 | Other F | 34.5K | $1.1M |
| May 20, 2026 | Pulik Richard KEY | Other F | 19.0K | $614.6K |
| Apr 20, 2026 | Venker Eric KEY 10b5-1 | Exercise M | 200.0K | $0 |
| Apr 20, 2026 | Venker Eric KEY 10b5-1 | Sell S | 200.0K | $5.9M |
| Apr 20, 2026 | Venker Eric KEY 10b5-1 | Exercise M | 200.0K | $770.0K |
| Apr 20, 2026 | Pulik Richard KEY | Grant A | 84.0K | $0 |
| Apr 20, 2026 | Pulik Richard KEY | Grant A | 60.6K | $0 |
| Apr 20, 2026 | Humes Jennifer | Grant A | 27.2K | $0 |
| Apr 20, 2026 | Humes Jennifer | Grant A | 29.2K | $0 |
| Apr 17, 2026 | Oren Ilan | Other F | 95 | $2.8K |
| Apr 17, 2026 | Oren Ilan | Grant A | 896 | $0 |
| Apr 17, 2026 | MOMTAZEE JAMES C | Other F | 94 | $2.8K |
| Apr 17, 2026 | MOMTAZEE JAMES C | Grant A | 469 | $0 |
| Apr 17, 2026 | Epperly Melissa B, | Grant A | 670 | $0 |
| Apr 16, 2026 | Gline Matthew KEY | Sell S | 289.8K | $8.4M |
| Apr 8, 2026 | Humes Jennifer | Sell S | 13.5K | $384.1K |
| Mar 31, 2026 | Sukhatme Mayukh KEY | Other F | 187.5K | $5.2M |
| Mar 31, 2026 | Gline Matthew KEY | Other F | 304.7K | $8.4M |
| Mar 31, 2026 | Torti Frank KEY | Other F | 160.0K | $4.4M |
| Mar 30, 2026 | Sukhatme Mayukh KEY | Exercise M | 1.3M | $15.0M |
| Mar 30, 2026 | Sukhatme Mayukh KEY | Other F | 29.8K | $787.3K |
| Mar 30, 2026 | Sukhatme Mayukh KEY | Exercise M | 58.4K | — |
| Mar 30, 2026 | Gline Matthew KEY | Exercise M | 2.2M | $25.0M |
| Mar 30, 2026 | Gline Matthew KEY | Other F | 53.8K | $1.4M |
| Mar 30, 2026 | Gline Matthew KEY | Exercise M | 97.3K | — |
| Mar 26, 2026 | Fitzgerald Meghan | Exercise M | 70.0K | $0 |
| Mar 26, 2026 | Fitzgerald Meghan | Sell S | 70.0K | $1.9M |
| Mar 26, 2026 | Fitzgerald Meghan | Exercise M | 70.0K | $616.0K |
| Mar 20, 2026 | Humes Jennifer | Other F | 14.5K | $402.4K |
| Mar 20, 2026 | Pulik Richard KEY | Other F | 1.5K | $42.8K |
| Mar 17, 2026 | Venker Eric KEY 10b5-1 | Exercise M | 200.0K | $0 |
| Mar 17, 2026 | Venker Eric KEY 10b5-1 | Exercise M | 200.0K | $770.0K |
| Mar 17, 2026 | Venker Eric KEY 10b5-1 | Sell S | 200.0K | $5.6M |
| Mar 16, 2026 | Epperly Melissa B, | Sell S | 41.9K | $1.2M |
| Feb 23, 2026 | Torti Frank KEY 10b5-1 | Exercise M | 587.4K | $0 |
| Feb 23, 2026 | Torti Frank KEY 10b5-1 | Sell S | 587.4K | $16.2M |
| Feb 23, 2026 | Torti Frank KEY 10b5-1 | Exercise M | 587.4K | $2.3M |
| Feb 20, 2026 | Torti Frank KEY 10b5-1 | Exercise M | 1.0M | $0 |
| Feb 20, 2026 | Torti Frank KEY 10b5-1 | Sell S | 1.0M | $27.5M |
| Feb 20, 2026 | Torti Frank KEY 10b5-1 | Exercise M | 1.0M | $3.9M |
| Feb 20, 2026 | Pulik Richard KEY | Other F | 1.0K | $27.1K |
| Feb 20, 2026 | Venker Eric KEY | Other F | 7.1K | $191.4K |
| Feb 19, 2026 | Torti Frank KEY 10b5-1 | Exercise M | 1.4M | $0 |
| Feb 19, 2026 | Torti Frank KEY 10b5-1 | Sell S | 1.4M | $38.4M |
| Feb 19, 2026 | Torti Frank KEY 10b5-1 | Exercise M | 1.4M | $5.4M |
| Feb 13, 2026 | QVT Financial LP | Sell S | 150.8K | $4.0M |
| Feb 13, 2026 | QVT Financial LP | Sell S | 225.0K | $6.0M |
| Feb 13, 2026 | MANCHESTER KEITH S | Sell S | 225.0K | $6.0M |
| Feb 13, 2026 | MANCHESTER KEITH S | Sell S | 150.8K | $4.0M |
| Feb 13, 2026 | Gold Daniel Allen | Sell S | 150.8K | $4.0M |
| Feb 13, 2026 | Gold Daniel Allen | Sell S | 225.0K | $6.0M |
| Feb 13, 2026 | Venker Eric KEY 10b5-1 | Exercise M | 200.0K | $0 |
| Feb 13, 2026 | Venker Eric KEY 10b5-1 | Exercise M | 200.0K | $770.0K |
| Feb 13, 2026 | Venker Eric KEY 10b5-1 | Sell S | 200.0K | $5.3M |
| Feb 12, 2026 | QVT Financial LP | Sell S | 275.0K | $7.4M |
| Feb 12, 2026 | QVT Financial LP | Sell S | 150.0K | $4.0M |
| Feb 12, 2026 | MANCHESTER KEITH S | Sell S | 150.0K | $4.0M |
| Feb 12, 2026 | MANCHESTER KEITH S | Sell S | 275.0K | $7.4M |
| Feb 12, 2026 | Gold Daniel Allen | Sell S | 275.0K | $7.4M |
| Feb 12, 2026 | Gold Daniel Allen | Sell S | 150.0K | $4.0M |
| Feb 11, 2026 | QVT Financial LP | Sell S | 425.0K | $11.3M |
| Feb 11, 2026 | MANCHESTER KEITH S | Sell S | 425.0K | $11.3M |
| Feb 11, 2026 | Gold Daniel Allen | Sell S | 425.0K | $11.3M |
| Feb 9, 2026 | Sukhatme Mayukh KEY | Exercise M | 651.6K | $0 |
| Feb 9, 2026 | Sukhatme Mayukh KEY | Other J | 312.1K | $8.3M |
| Feb 9, 2026 | Sukhatme Mayukh KEY | Exercise M | 651.6K | $8.3M |
| Feb 9, 2026 | Sukhatme Mayukh KEY | Sell S | 339.4K | $9.0M |
| Jan 20, 2026 | Oren Ilan | Other F | 124 | $2.8K |
| Jan 20, 2026 | Oren Ilan | Grant A | 1.2K | $0 |
| Jan 20, 2026 | Epperly Melissa B, | Grant A | 815 | $0 |
| Jan 20, 2026 | Epperly Melissa B, | Other F | 54 | $1.2K |
| Jan 20, 2026 | MOMTAZEE JAMES C | Grant A | 609 | $0 |
| Jan 20, 2026 | MOMTAZEE JAMES C | Other F | 122 | $2.8K |
| Jan 12, 2026 | Venker Eric KEY 10b5-1 | Exercise M | 200.0K | $0 |
| Jan 12, 2026 | Venker Eric KEY 10b5-1 | Exercise M | 200.0K | $770.0K |
| Jan 12, 2026 | Venker Eric KEY 10b5-1 | Sell S | 200.0K | $4.4M |
| Dec 31, 2025 | Sukhatme Mayukh KEY | Exercise M | 2.4M | $0 |
| Dec 31, 2025 | Sukhatme Mayukh KEY | Exercise M | 2.4M | $31.1M |
| Dec 31, 2025 | Sukhatme Mayukh KEY | Sell S | 1.0M | $22.1M |
| Dec 31, 2025 | Sukhatme Mayukh KEY | Other J | 1.4M | $31.1M |
| Dec 29, 2025 | Sukhatme Mayukh KEY | Exercise M | 748.4K | $0 |
| Dec 29, 2025 | Sukhatme Mayukh KEY | Other J | 436.5K | $9.5M |
| Dec 29, 2025 | Sukhatme Mayukh KEY | Exercise M | 748.4K | $9.5M |
| Dec 29, 2025 | Sukhatme Mayukh KEY | Sell S | 311.9K | $6.8M |
| Dec 24, 2025 | Torti Frank KEY | Other G | 110.5K | $0 |
| Dec 24, 2025 | Torti Frank KEY | Other J | 64.9K | $1.5M |
| Dec 24, 2025 | Venker Eric KEY | Exercise M | 117.8K | $0 |
| Dec 24, 2025 | Venker Eric KEY | Exercise M | 117.8K | $453.7K |
| Dec 24, 2025 | Venker Eric KEY | Sell S | 75.0K | $1.7M |
| Dec 23, 2025 | Torti Frank KEY | Grant A | 175.4K | $3.9M |
| Dec 23, 2025 | Pulik Richard KEY | Exercise M | 260.0K | $0 |
| Dec 23, 2025 | Pulik Richard KEY | Exercise M | 260.0K | $1.0M |
| Dec 23, 2025 | Pulik Richard KEY | Sell S | 260.0K | $5.8M |
| Dec 23, 2025 | Pulik Richard KEY | Sell S | 146.7K | $3.3M |
| Dec 23, 2025 | Venker Eric KEY | Exercise M | 313.8K | $0 |
| Dec 23, 2025 | Venker Eric KEY | Exercise M | 313.8K | $1.2M |
| Dec 23, 2025 | Venker Eric KEY | Sell S | 200.0K | $4.5M |
| Dec 20, 2025 | Pulik Richard KEY | Other F | 2.1K | $47.7K |
| Dec 17, 2025 | MANCHESTER KEITH S | Sell S | 155.1K | $3.6M |
| Dec 17, 2025 | MANCHESTER KEITH S | Sell S | 432.7K | $10.0M |
| Dec 17, 2025 | MANCHESTER KEITH S | Sell S | 189.5K | $4.4M |
| Dec 17, 2025 | Gold Daniel Allen | Sell S | 432.7K | $10.0M |
| Dec 17, 2025 | Gold Daniel Allen | Sell S | 155.1K | $3.6M |
| Dec 17, 2025 | Gold Daniel Allen | Sell S | 189.5K | $4.4M |
| Dec 17, 2025 | QVT Financial LP | Sell S | 155.1K | $3.6M |
| Dec 17, 2025 | QVT Financial LP | Sell S | 189.5K | $4.4M |
| Dec 17, 2025 | QVT Financial LP | Sell S | 432.7K | $10.0M |
| Dec 17, 2025 | Sukhatme Mayukh KEY | Exercise M | 59.5K | $0 |
| Dec 17, 2025 | Sukhatme Mayukh KEY | Exercise M | 59.5K | $754.6K |
| Dec 17, 2025 | Sukhatme Mayukh KEY | Sell S | 26.8K | $619.5K |
| Dec 17, 2025 | Sukhatme Mayukh KEY | Other J | 32.7K | $754.6K |
| Dec 16, 2025 | MANCHESTER KEITH S | Sell S | 642.3K | $14.8M |
| Dec 16, 2025 | MANCHESTER KEITH S | Sell S | 275.0K | $6.3M |
| Dec 16, 2025 | Gold Daniel Allen | Sell S | 275.0K | $6.3M |
| Dec 16, 2025 | Gold Daniel Allen | Sell S | 642.3K | $14.8M |
| Dec 16, 2025 | QVT Financial LP | Sell S | 275.0K | $6.3M |
| Dec 16, 2025 | QVT Financial LP | Sell S | 642.3K | $14.8M |
| Dec 15, 2025 | Ramaswamy Vivek | Exercise M | 832.5K | $0 |
| Dec 15, 2025 | Ramaswamy Vivek | Sell S | 353.7K | $7.8M |
| Dec 15, 2025 | Ramaswamy Vivek | Exercise M | 832.5K | $10.6M |
| Dec 15, 2025 | Ramaswamy Vivek | Other J | 478.7K | $10.6M |
| Dec 15, 2025 | Gline Matthew KEY | Exercise M | 1.4M | $0 |
| Dec 15, 2025 | Gline Matthew KEY | Exercise M | 234.1K | $0 |
| Dec 15, 2025 | Gline Matthew KEY | Exercise M | 2.3M | $0 |
| Dec 15, 2025 | Gline Matthew KEY | Other J | 1.3M | $28.8M |
| Dec 15, 2025 | Gline Matthew KEY | Other J | 797.6K | $17.3M |
| Dec 15, 2025 | Gline Matthew KEY | Sell S | 566.1K | $12.3M |
| Dec 15, 2025 | Gline Matthew KEY | Exercise M | 1.4M | $17.3M |
| Dec 15, 2025 | Gline Matthew KEY | Sell S | 230.4K | $5.0M |
| Dec 15, 2025 | Gline Matthew KEY | Exercise M | 234.1K | $950.4K |
| Dec 15, 2025 | Gline Matthew KEY | Exercise M | 2.3M | $28.8M |
| Dec 15, 2025 | Gline Matthew KEY | Other J | 3.7K | $81.1K |
| Dec 15, 2025 | Gline Matthew KEY | Sell S | 943.5K | $20.5M |
| Dec 12, 2025 | Ramaswamy Vivek | Exercise M | 4.7M | $0 |
| Dec 12, 2025 | Ramaswamy Vivek | Sell S | 2.0M | $43.4M |
| Dec 12, 2025 | Ramaswamy Vivek | Other J | 2.7M | $59.2M |
| Dec 12, 2025 | Ramaswamy Vivek | Exercise M | 4.7M | $59.3M |
| Dec 11, 2025 | Ramaswamy Vivek | Exercise M | 1.9M | $0 |
| Dec 11, 2025 | Ramaswamy Vivek | Other J | 1.1M | $23.7M |
| Dec 11, 2025 | Ramaswamy Vivek | Sell S | 774.1K | $16.8M |
| Dec 11, 2025 | Ramaswamy Vivek | Exercise M | 1.9M | $23.7M |
| Dec 9, 2025 | Venker Eric KEY 10b5-1 | Exercise M | 200.0K | $0 |
| Dec 9, 2025 | Venker Eric KEY 10b5-1 | Sell S | 200.0K | $4.2M |
| Dec 9, 2025 | Venker Eric KEY 10b5-1 | Exercise M | 200.0K | $770.0K |
| Nov 20, 2025 | Venker Eric KEY | Other F | 7.1K | $142.9K |
| Nov 20, 2025 | Pulik Richard KEY | Other F | 1.2K | $25.0K |
| Nov 19, 2025 | QVT Financial LP | Sell S | 150.0K | $3.0M |
| Nov 19, 2025 | QVT Financial LP | Sell S | 125.0K | $2.5M |
| Nov 19, 2025 | QVT Financial LP | Sell S | 175.0K | $3.5M |
| Nov 19, 2025 | QVT Financial LP | Sell S | 850.0K | $17.2M |
| Nov 19, 2025 | MANCHESTER KEITH S | Sell S | 175.0K | $3.5M |
| Nov 19, 2025 | MANCHESTER KEITH S | Sell S | 125.0K | $2.5M |
| Nov 19, 2025 | MANCHESTER KEITH S | Sell S | 150.0K | $3.0M |
| Nov 19, 2025 | MANCHESTER KEITH S | Sell S | 850.0K | $17.2M |
| Nov 19, 2025 | Gold Daniel Allen | Sell S | 850.0K | $17.2M |
| Nov 19, 2025 | Gold Daniel Allen | Sell S | 175.0K | $3.5M |
| Nov 19, 2025 | Gold Daniel Allen | Sell S | 125.0K | $2.5M |
| Nov 19, 2025 | Gold Daniel Allen | Sell S | 150.0K | $3.0M |
| Nov 17, 2025 | Ramaswamy Vivek | Sell S | 539.6K | $11.1M |
| Nov 14, 2025 | Ramaswamy Vivek | Sell S | 1.0M | $20.9M |
| Nov 13, 2025 | Ramaswamy Vivek | Sell S | 287.3K | $6.0M |
| Nov 7, 2025 | Venker Eric KEY 10b5-1 | Exercise M | 200.0K | $4.0M |
| Nov 7, 2025 | Venker Eric KEY 10b5-1 | Sell S | 200.0K | $4.0M |
| Nov 7, 2025 | Venker Eric KEY 10b5-1 | Exercise M | 200.0K | $770.0K |
| Oct 20, 2025 | MOMTAZEE JAMES C | Other F | 158 | $2.8K |
| Oct 20, 2025 | MOMTAZEE JAMES C | Grant A | 789 | $0 |
| Oct 20, 2025 | Epperly Melissa B, | Grant A | 1.1K | $0 |
| Oct 20, 2025 | Oren Ilan | Other F | 281 | $5.0K |
| Oct 20, 2025 | Oren Ilan | Grant A | 1.5K | $0 |
| Oct 17, 2025 | Venker Eric KEY 10b5-1 | Exercise M | 118.4K | $0 |
| Oct 17, 2025 | Venker Eric KEY 10b5-1 | Exercise M | 118.4K | $1.9M |
| Oct 17, 2025 | Venker Eric KEY 10b5-1 | Sell S | 118.4K | $2.0M |
| Oct 16, 2025 | Venker Eric KEY 10b5-1 | Exercise M | 318.3K | $0 |
| Oct 16, 2025 | Venker Eric KEY 10b5-1 | Exercise M | 318.3K | $5.0M |
| Oct 16, 2025 | Venker Eric KEY 10b5-1 | Sell S | 318.3K | $5.4M |
| Oct 15, 2025 | Venker Eric KEY 10b5-1 | Exercise M | 414.7K | $0 |
| Oct 15, 2025 | Venker Eric KEY 10b5-1 | Sell S | 414.7K | $7.0M |
| Oct 15, 2025 | Venker Eric KEY 10b5-1 | Exercise M | 414.7K | $6.6M |
| Oct 13, 2025 | Venker Eric KEY 10b5-1 | Exercise M | 20.7K | $0 |
| Oct 13, 2025 | Venker Eric KEY 10b5-1 | Exercise M | 20.7K | $328.5K |
| Oct 13, 2025 | Venker Eric KEY 10b5-1 | Sell S | 20.7K | $336.8K |
| Oct 9, 2025 | Venker Eric KEY 10b5-1 | Exercise M | 104.9K | $0 |
| Oct 9, 2025 | Venker Eric KEY 10b5-1 | Sell S | 104.9K | $1.7M |
| Oct 9, 2025 | Venker Eric KEY 10b5-1 | Exercise M | 104.9K | $1.7M |
| Oct 8, 2025 | Venker Eric KEY 10b5-1 | Exercise M | 10.3K | $0 |
| Oct 8, 2025 | Venker Eric KEY 10b5-1 | Exercise M | 128.3K | $0 |
| Oct 8, 2025 | Venker Eric KEY 10b5-1 | Sell S | 138.6K | $2.2M |
| Oct 8, 2025 | Venker Eric KEY 10b5-1 | Exercise M | 128.3K | $955.8K |
| Oct 8, 2025 | Venker Eric KEY 10b5-1 | Exercise M | 10.3K | $163.4K |
| Oct 7, 2025 | Venker Eric KEY 10b5-1 | Exercise M | 67.2K | $0 |
| Oct 7, 2025 | Venker Eric KEY 10b5-1 | Exercise M | 107.1K | $0 |
| Oct 7, 2025 | Venker Eric KEY 10b5-1 | Exercise M | 180.9K | $0 |
| Oct 7, 2025 | Venker Eric KEY 10b5-1 | Exercise M | 107.1K | $798.1K |
| Oct 7, 2025 | Venker Eric KEY 10b5-1 | Sell S | 355.2K | $5.7M |
| Oct 7, 2025 | Venker Eric KEY 10b5-1 | Exercise M | 180.9K | $696.3K |
| Oct 7, 2025 | Venker Eric KEY 10b5-1 | Exercise M | 67.2K | $1.1M |
| Oct 6, 2025 | Venker Eric KEY 10b5-1 | Exercise M | 127.4K | $0 |
About ROIV insider trading
This page tracks insider transactions for Roivant Sciences Ltd. (ROIV) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.